Beta Blockers for POTS: Evidence, Benefits, and What Patients Should Know (Washington State POTS Clinic)
- Katherine Bachenberg
- Nov 21
- 4 min read
💊 Beta Blockers for POTS: What the Research Shows & Who They Help
Postural Orthostatic Tachycardia Syndrome (POTS) affects millions of people and often leads to rapid heart rate, dizziness, fatigue, and brain fog when standing. While there is no FDA-approved medication specifically for POTS, beta blockers remain one of the most widely studied off-label treatments.
At Galene Health Clinic in Bellingham, WA, we specialize in POTS and autonomic disorders, offering both in-person care and telehealth throughout Washington State. This guide explains what current research shows about beta blockers, how they work, who benefits, and how we incorporate them into individualized POTS treatment plans.
💊 What Are Beta Blockers — and Why Are They Used in POTS?
Beta blockers block β-adrenergic receptors, reducing the effects of adrenaline. In POTS, where sympathetic activation and tachycardia are often excessive, this can help:
Reduce standing heart rate
Improve palpitations
Reduce exercise-induced tachycardia
Blunt the overstimulated “fight-or-flight” response
Guidelines and reviews identify beta blockers as a first-line pharmacologic option for POTS when tachycardia is the predominant symptom.
Common beta blockers used for POTS:
Propranolol (most studied)
Metoprolol
Bisoprolol
💊 What Peer-Reviewed Research Says
Low-Dose Propranolol Has the Best Evidence
A landmark double-blind, randomized crossover trial (Circulation, 2009) studied propranolol in POTS. Findings:
Low-dose propranolol (20 mg) significantly reduced tachycardia.
It improved acute symptom burden more than placebo.
Higher doses (80 mg) did NOT improve symptoms and sometimes worsened fatigue.
A 2013 Neurology trial showed similar findings:
20 mg propranolol improved exercise capacity (peak VO₂).
Higher-dose propranolol or high-dose metoprolol lowered HR but did not improve exercise performance.
Clinical takeaway:Low doses—not high doses—seem to work best in POTS.
Beta Blockers as a Class Show Benefit
A 2025 systematic review (Frontiers in Neurology) concluded that ivabradine, midodrine, and beta blockers have the strongest evidence for treating POTS.
Beta blockers consistently:
Reduce standing heart rate
Improve palpitations
Improve overall symptom scores in many patients
But they are not effective for every POTS phenotype, especially hypovolemic or low-blood-pressure POTS.
Metoprolol Studies — Especially in Pediatric POTS
In pediatric and adolescent studies:
Metoprolol improved symptoms and HR control for many patients.
Response was best in patients with elevated upright norepinephrine, supporting the idea that hyperadrenergic POTS responds most strongly.
Biomarkers like C-type natriuretic peptide (CNP) and specific HR parameters predict response.
Real-World Use and Expert Guidelines
Reviews from autonomic experts and cardiovascular societies recommend:
Non-pharmacologic therapy first
Beta blockers for patients with prominent tachycardia or hyperadrenergic features
Avoiding them or using cautiously in hypotensive, hypovolemic, or very fatigued patients
💊 Who Beta Blockers Help the Most
You may benefit if you have:
Hyperadrenergic POTS
Significant tachycardia as your most disabling symptom
Palpitations, adrenaline surges, or anxiety-like autonomic activation
Normal or elevated standing blood pressure
They may be LESS helpful if you:
Have low blood pressure
Have low blood volume
Experience severe fatigue
Have asthma (non-selective beta blockers may worsen bronchospasm)
💊 How Beta Blockers Fit Into a POTS Treatment Plan
At Galene Health Clinic, we use a whole-person POTS approach rooted in evidence:
1. Foundational Non-Medication Care
Hydration + sodium optimization
Compression garments
Heat avoidance
Sleep optimization
Graded, recumbent-first exercise
2. Targeted Medications
If symptoms remain disabling, we consider beta blockers or alternatives like:
Ivabradine (for low-BP patients)
Midodrine (for low BP or venous pooling)
Fludrocortisone (volume expansion)
Beta blockers are typically used in low doses at first—based directly on the clinical patterns supported by research.
💊 Are Beta Blockers Safe for POTS?
Common side effects:
Fatigue
Lightheadedness
Cold extremities
Sleep changes
Lower exercise capacity at higher doses
Low-dose regimens tend to be much better tolerated.
Never stop a beta blocker abruptly—it may cause rebound tachycardia.
Pregnancy use requires individual risk-benefit discussion.
💊 Comparison With Other POTS Medications
Medication | Best For | Evidence Level |
Beta blockers | Hyperadrenergic POTS, tachycardia-dominant | Strongest evidence, esp. propranolol |
Ivabradine | Low BP + high HR | RCTs show significant improvement |
Midodrine | Low BP, venous pooling | High response rate in pediatric POTS |
Fludrocortisone | Hypovolemia | Modest evidence |
Systematic reviews emphasize ivabradine, midodrine, and beta blockers as the strongest pharmacologic options to date.
💊 How We Use Beta Blockers at Galene Health Clinic
At Galene Health Clinic in Bellingham, WA, we take a precision-guided approach:
Full autonomic history + symptom mapping
Orthostatic vitals or tilt test interpretation
Cardiac screening to ensure safety
Slow uptitration based on your daily function
Adjustments based on blood pressure, fatigue, HR patterns, and activity level
We provide:
✔ In-person POTS care in Bellingham
✔ Telehealth POTS visits across Washington State
💊 FAQ
Do beta blockers actually help POTS?
Yes. Multiple randomized trials show low-dose propranolol improves tachycardia, symptoms, and even exercise capacity.
What dose of beta blockers works for POTS?
Studies support low-dose propranolol (10–20 mg) and cautious titration of selective agents like metoprolol.
Can I use beta blockers if my blood pressure is low?
Probably not. They may worsen symptoms if BP is low or blood volume is reduced.
Are beta blockers safe long-term for POTS?
Evidence suggests they are generally safe, but long-term management should be individualized.
💊 When to See a POTS Specialist in Washington State
If you experience:
Severe tachycardia
Lightheadedness
Exercise intolerance
Post-viral or post-COVID POTS symptoms
Our clinic offers comprehensive POTS evaluations and medication management, including beta blockers when appropriate.
💊 Peer-Reviewed References
Raj SR et al. Circulation, 2009. https://www.ahajournals.org/doi/10.1161/circulationaha.108.846501
Arnold AC et al. Neurology, 2013. https://www.neurology.org/doi/10.1212/WNL.0b013e318293e310
Pierson BC et al. Front Neurol, 2025. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1515486/full
Miller AJ & Raj SR. Auton Neurosci, 2018. https://pubmed.ncbi.nlm.nih.gov/29753556/
Wells R et al. Mayo Clin Proc, 2018. https://www.mayoclinicproceedings.org/article/S0025-6196%2818%2930111-3/abstract?
Zhang Q et al. J Transl Med, 2014.https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-014-0249-3
Lin J et al. PLoS One, 2015. https://pubmed.ncbi.nlm.nih.gov/25811760/
Xu BW et al. Children (Basel), 2023. https://link.springer.com/article/10.1007/s12519-022-00677-4
Boris JR et al. Pediatrics, 2022. https://pubmed.ncbi.nlm.nih.gov/35773520/
Moon J et al. Clin Auton Res, 2018. https://www.sciencedirect.com/science/article/pii/S1878747923010619




Comments